Correlation Between TC BioPharm and Glaukos Corp
Can any of the company-specific risk be diversified away by investing in both TC BioPharm and Glaukos Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TC BioPharm and Glaukos Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TC BioPharm plc and Glaukos Corp, you can compare the effects of market volatilities on TC BioPharm and Glaukos Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TC BioPharm with a short position of Glaukos Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of TC BioPharm and Glaukos Corp.
Diversification Opportunities for TC BioPharm and Glaukos Corp
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between TCBPW and Glaukos is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding TC BioPharm plc and Glaukos Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Glaukos Corp and TC BioPharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TC BioPharm plc are associated (or correlated) with Glaukos Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Glaukos Corp has no effect on the direction of TC BioPharm i.e., TC BioPharm and Glaukos Corp go up and down completely randomly.
Pair Corralation between TC BioPharm and Glaukos Corp
Assuming the 90 days horizon TC BioPharm plc is expected to generate 34.03 times more return on investment than Glaukos Corp. However, TC BioPharm is 34.03 times more volatile than Glaukos Corp. It trades about 0.12 of its potential returns per unit of risk. Glaukos Corp is currently generating about 0.09 per unit of risk. If you would invest 2.26 in TC BioPharm plc on September 12, 2024 and sell it today you would lose (0.65) from holding TC BioPharm plc or give up 28.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 85.8% |
| Values | Daily Returns |
TC BioPharm plc vs. Glaukos Corp
Performance |
| Timeline |
| TC BioPharm plc |
| Glaukos Corp |
TC BioPharm and Glaukos Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with TC BioPharm and Glaukos Corp
The main advantage of trading using opposite TC BioPharm and Glaukos Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TC BioPharm position performs unexpectedly, Glaukos Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Glaukos Corp will offset losses from the drop in Glaukos Corp's long position.| TC BioPharm vs. Equillium | TC BioPharm vs. DiaMedica Therapeutics | TC BioPharm vs. Valneva SE ADR | TC BioPharm vs. Vivani Medical |
| Glaukos Corp vs. Heart Test Laboratories | Glaukos Corp vs. Inspira Technologies Oxy | Glaukos Corp vs. TC BioPharm plc | Glaukos Corp vs. bioAffinity Technologies Warrant |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Other Complementary Tools
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |